Email: cspc@cspc.cn
News
News Center
Nov. 03
2026
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2072 TABLETS FOR THE TREATMENT OF UNCONTROLLED HYPERTENSION AND RESISTANT HYPERTENSION OFFICIALLY INITIAT
VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6088 INJECTION FOR THE TREATMENT OF ADVANCED SOLID TUMOURS OFFICIALLY INITIATED AT THE FIRST CENTRE IN
Nov. 02
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYS6057 (RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS VACCINE (CHO CELLS)) OFFICIALLY INITIATED IN CHINA
VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6052 (RECOMBINANT HERPES ZOSTER VIRUS VACCINE (CHO CELLS)) OFFICIALLY INITIATED IN CHINA
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF PRUSOGLIPTIN TABLETS IN COMBINATION WITH DAPAGLIFLOZIN TABLETS AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE
Oct. 30
VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6043 FOR THE TREATMENT OF ADVANCED SOLID TUMOURS OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us